# OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oceans-a-randomized-double-blind-placebo-controlled-phase-iii-trial-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Carol Aghajanian,Stephanie V. Blank,Barbara A. Goff,Patricia L. Judson,Michael Teneriello,Amreen Husain,Mika A. Sovak,Jing Yi,Lawrence R. Nycum |
| Citations | 1,379 |
| DOI | 10.1200/jco.2012.42.0505 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.42.0505?role=tab |
| OpenAlex ID | https://openalex.org/W2171658624 |
| PMID | 22529265 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Carol Aghajanian](https://scholariq.org/researchers/carol-aghajanian/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.